CA1250573A - 2,4,diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine en fine poudre et ses sels d'addition avec les acides, acceptables en pharmacie - Google Patents

2,4,diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine en fine poudre et ses sels d'addition avec les acides, acceptables en pharmacie

Info

Publication number
CA1250573A
CA1250573A CA000420582A CA420582A CA1250573A CA 1250573 A CA1250573 A CA 1250573A CA 000420582 A CA000420582 A CA 000420582A CA 420582 A CA420582 A CA 420582A CA 1250573 A CA1250573 A CA 1250573A
Authority
CA
Canada
Prior art keywords
microns
average particle
particle diameter
pharmaceutically acceptable
diamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000420582A
Other languages
English (en)
Inventor
Hiroshi Enomoto
Yoshiaki Aoyagi
Fusao Ueda
Akira Nomura
Masanobu Kawamata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Priority to CA000420582A priority Critical patent/CA1250573A/fr
Application granted granted Critical
Publication of CA1250573A publication Critical patent/CA1250573A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA000420582A 1983-01-31 1983-01-31 2,4,diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine en fine poudre et ses sels d'addition avec les acides, acceptables en pharmacie Expired CA1250573A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000420582A CA1250573A (fr) 1983-01-31 1983-01-31 2,4,diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine en fine poudre et ses sels d'addition avec les acides, acceptables en pharmacie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000420582A CA1250573A (fr) 1983-01-31 1983-01-31 2,4,diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine en fine poudre et ses sels d'addition avec les acides, acceptables en pharmacie

Publications (1)

Publication Number Publication Date
CA1250573A true CA1250573A (fr) 1989-02-28

Family

ID=4124458

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000420582A Expired CA1250573A (fr) 1983-01-31 1983-01-31 2,4,diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine en fine poudre et ses sels d'addition avec les acides, acceptables en pharmacie

Country Status (1)

Country Link
CA (1) CA1250573A (fr)

Similar Documents

Publication Publication Date Title
AU630086B2 (en) Anticalculus oral composition
EP0297213B1 (fr) Traitement oral et utilisation d'une composition orale
JPH0713009B2 (ja) 歯磨き組成物
FI77156B (fi) Foerfarande foer framstaellning av en fast vismuthaltig komposition.
IE913796A1 (en) Improved anti-plaque compositions comprising a combination¹of morpholinoamino alcohol and chelating agent
US4837255A (en) Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
KR100238565B1 (ko) 상부 위장관 통증을 치료하기 위한 섭취가능한 약학적 조성물
CA1250573A (fr) 2,4,diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine en fine poudre et ses sels d'addition avec les acides, acceptables en pharmacie
US4532238A (en) Finely pulverized 2,4-diamino-6-(2,5-dichloro-phenyl)-1,3,5-triazine and pharmaceutically acceptable acid addition salts thereof
IL31858A (en) Concentrated liquid mixtures against acids
KR101930386B1 (ko) 금연 보조용 조성물 및 이를 포함하는 구강 위생 제품
US5411993A (en) Anti-inflammatory, stable aqueous preparation comprising azulene sodium sulfonate and polyhydric alcohol
US4346082A (en) Method of employing therapeutic composition comprising ammonium or substituted ammonium compounds for treatment of alcoholism
US4436721A (en) Oral composition having mole ratio of tetra (methylene phosphonate) to alkali metal fluoride of at least 1.4:1
US4296094A (en) Dental cleaning composition and method
DK165966B (da) Forbedret piroxicamholdigt anti-inflammatorisk praeparat
US3228844A (en) Method for reducing incidence of dental caries with vitamin b6
US4146608A (en) Synergistic anti-plaque mixture with tetradecylamine and copper, iron, nickel, or cobalt
US6075048A (en) Pediatric method of use of bambuterol
JPS648602B2 (fr)
EP0114908B1 (fr) 2,4-Diamino-6-(2,5-dichlorophényl)-1,3,5-triazine finement pulvérisée et les sels d'addition d'acides pharmaceutiquement acceptables
US3360434A (en) Method for reducing blood pressure with phenylalanine derivatives
JPS6140217A (ja) 腫瘍形成抑制用組成物
AU607744B2 (en) Hypocholesterolaemic gel formulation containing a pharmaceutically acceptable nondigestible anion exchange resin
EP0059031B1 (fr) Composition analgésique et anti-inflammatoire

Legal Events

Date Code Title Description
MKEX Expiry